ActiGraph Announces Grant to Accelerate Digital Endpoint Research

PENSACOLA, FL, August 31, 2022–ActiGraph, a leading provider of wearable technology-enabled...

ActiGraph Rolls Out New Data Science Services to Accelerate Clinical Development

PENSACOLA, FL, June 21, 2022–ActiGraph, a leading provider of wearable technology-enabled...

ActiGraph Establishes New Scientific Advisory Board of Clinical Research Experts

PENSACOLA, FL, June 2, 2022–ActiGraph, a leading provider of wearable technology-enabled...

ActiGraph Expands Headquarters in Downtown Pensacola

PENSACOLA, FL, May 2, 2022–ActiGraph, a leading provider of wearable technology-enabled...

ActiGraph Joins Decentralized Trials & Research Alliance

**PENSACOLA, FL, March 29, 2022 – **ActiGraph, a leading provider of wearable technology-enabled...

ActiGraph Announces Significant Technology Upgrades for Clinical Trials

Pensacola, FL – February 17, 2022–ActiGraph, a leading technology partner for clinical trials and...

ActiGraph Expands Executive Leadership Team with Two New C-Level Hires

Pensacola, FL – July 13, 2021–ActiGraph, a global leader in wearable digital biomarker technology...

ActiGraph Announces Official Partnership with Chinese Reseller, B&E Teksystems

Pensacola, FL – May 24, 2021–ActiGraph, a leading global provider of medical-grade wearable...

VeraSci Partners with ActiGraph to Expand the Use of Wearables in Clinical Trials

Durham, NC – January 19, 2021–VeraSci, a global clinical research company offering eClinical...

ActiGraph Promotes Jeremy Wyatt to Chief Executive Officer

Pensacola, FL – June 8, 2020– ActiGraph, a leading provider of medical-grade wearable physical...